Illumina Expands Genotyping Deal With GlaxoSmithKline | GenomeWeb
NEW YORK (GenomeWeb News) – Illumina has expanded the scope of its multi-year genotyping services agreement with GlaxoSmithKline, Illumina said today.
 
Under the new agreement, Illumina will use its Sentrix HumanHap550 BeadChips for a series of whole-genome association studies.
 
As the first study, Illumina will genotype a collection of 2,000 case and control DNA samples provided by GSK for an undisclosed disease.
 
Financial details were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.